Skip to main content
Triochem Products Ltd. logo

Triochem Products Ltd. — Investor Relations & Filings

Ticker · 512101 ISIN · INE331E01013 BSE.NS Manufacturing
Open in API
Filings indexed 442 across all filing types
Latest filing 2024-05-27 Regulatory Filings
Country IN India
Listing BSE.NS 512101

About Triochem Products Ltd.

https://www.triochemproducts.com

Triochem Products Ltd. is a manufacturer and exporter specializing in Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. The company focuses on the production of high-quality chemical compounds for the global healthcare and pharmaceutical sectors. Its core product portfolio includes a range of specialized substances such as Quinine salts, Quinidine salts, and other niche therapeutic ingredients. Triochem Products Ltd. emphasizes adherence to stringent quality control measures and international regulatory standards to ensure the efficacy and safety of its chemical outputs. The organization serves a diverse clientele, providing essential raw materials for the formulation of various medications. By leveraging advanced chemical synthesis processes and technical expertise, the company maintains a significant presence in the supply chain for specialized pharmaceutical components.

Recent filings

Filing Released Lang Actions
This is to inform you that disclosures of the Related Party Transaction on a consolidated basis under regualtion 23(9) of SEBI (LODR) (Amendement) Regulations, 2018 is not applicable to our company.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) regarding the non-applicability of a specific regulation (Regulation 23(9) of SEBI (LODR) Amendments) to the company. It certifies the company's exemption under Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, based on paid-up capital and net worth thresholds. The document is a compliance notification or regulatory disclosure rather than a financial report or detailed governance report. It does not contain financial statements or detailed analysis but is a formal regulatory communication to the exchange. It is not an annual or interim report, audit report, or any other detailed filing but a regulatory filing informing about exemption status and compliance. Therefore, it fits best under Regulatory Filings (RNS). The document length is under 5,000 characters and is a direct communication to the exchange, consistent with RNS filings.
2024-05-27 English
This is to inform you that Annual Secretarial Compliance Report under Regulation 24A of SEBI (Listing Obligation and Disclosure Requirements) (Amendment) Regulation, 2018 read with BSE ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) regarding the non-applicability of Regulation 24A of SEBI (LODR) (Amendments) Regulation, 2018 for the company Triochem Products Limited. It certifies that the company is exempt from submitting the Annual Secretarial Compliance Report for the year ended 31st March 2024 due to its paid-up equity capital and net worth being below specified thresholds. The document is a regulatory compliance notification rather than a full report or financial statement. It does not contain financial data or detailed report content but serves as a formal regulatory filing to inform the exchange of the exemption status. The document length is short (3846 characters), and it is primarily a compliance declaration. Therefore, it fits best under Regulatory Filings (RNS).
2024-05-24 English
In compliance with regualtion 47 of SEBI (LODR) Regualtion 2015. Notice of Board Meeting dated 28th May 2024 publised in Navshakti and Free Press Journal on 21st May 2024
Regulatory Filings
2024-05-21 English
TRIOCHEM PRODUCTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 ,inter alia, to consider and approve 1) To consider, approve ....
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve the audited financial results for the quarter and year ended 31st March 2024, along with the Audit Report and the Notice of the 52nd Annual General Meeting. It is an intimation to the stock exchange under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The document does not contain the actual financial results or audit report but announces the upcoming board meeting where these will be considered. The document length is short (2315 characters) and serves as an announcement rather than the report itself. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and intimation rather than the Annual Report (10-K) or Audit Report (AR) themselves.
2024-05-20 English
Certificate issued by the practicing company secretary under regualtion 40(9) for the period from 01.04.2023 to 31.03.2024
Regulatory Filings Classification · 95% confidence The document is a Compliance Certificate issued under Regulation 40(9) of SEBI (LODR) Regulations, 2015, for the year ended 31.03.2024. It is addressed to the Corporate Relationship Department of BSE Limited and references compliance with a specific regulatory requirement related to share transfer or related processes. The document is short (1926 characters) and primarily serves as a certification or attestation rather than containing financial data or detailed report content. It does not contain financial statements or substantive financial analysis. Therefore, it fits the criteria for a Regulatory Filing (RNS) as it is a compliance certificate and not a full report or announcement of a report.
2024-04-19 English
Compalince Certificate by Share Transfer Agent for the year ended 31.03.2024
Regulatory Filings Classification · 95% confidence The document is a Compliance Certificate issued by the Share Transfer Agent under Regulation 7(3) and 7(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the year ended 31.03.2024. It is addressed to the stock exchange and confirms compliance activities related to share transfer facilities. The document length is 2836 characters, which is relatively short and primarily serves as a certification or attestation rather than a full financial or operational report. It does not contain financial statements, management discussion, or detailed report content. Therefore, it fits the category of Regulatory Filings (RNS), which includes officer certifications and compliance certificates that do not constitute full reports themselves.
2024-04-18 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.